Clinical Trials Logo
  1. Home
  2. Substance-Related Disorders
  3. NCT00000281
  4. Details
NCT00000281 Clinical Trial

Pharmacotherapy for Schizophrenic Drug Users - 6

Substance-Related Disorders Clinical Trial

Official title:
Pharmacotherapy for Schizophrenic Drug Users

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00000281
Other study ID # NIDA-09250-6
Secondary ID P50DA009250P50-0
Status Completed
Phase Phase 2
First received September 20, 1999
Last updated December 13, 2016
Start date September 1994
Est. completion date August 1999

Study information
Verified date December 2016
Source Yale University
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date August 1999
Est. primary completion date August 1999
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 55 Years
Eligibility Please contact site for information.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Amantadine

Locations
Country Name City State
United States VA Connecticut Healthcare System New Haven Connecticut

Sponsors (3)
Lead Sponsor Collaborator
Yale University National Institute on Drug Abuse (NIDA), VA Connecticut Healthcare System

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Drug use
Primary Retention
Primary Psychological symptoms
Primary Schizophrenic symptoms
See also
  Status Clinical Trial Phase
Recruiting NCT05054738 - CRP and S&A for Inpatient Veterans N/A
Recruiting NCT04157062 - An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder N/A
Completed NCT02233738 - Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services N/A
Enrolling by invitation NCT06084221 - Fatal Overdose Review Teams - Research to Enhance Surveillance Systems N/A
Completed NCT02907944 - Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation N/A
Completed NCT02570360 - Exercise and Treatment-as-usual in Substance Use Treatment Outcomes N/A
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02715557 - Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers N/A
Completed NCT02125539 - Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment Phase 2
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02388243 - The Computer-based Drug and Alcohol Training Assessment in Kenya N/A
Completed NCT01633138 - Performance-based Reinforcement to Enhance Cognitive Remediation Therapy N/A
Completed NCT02218970 - The Effect of Muscular Strength Training in Patients With Drug Addiction N/A
Completed NCT01591239 - Home-Based Program to Help Parents of Drug Abusing Adolescents N/A
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Withdrawn NCT01224002 - A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine N/A
Withdrawn NCT00891631 - Primary Care iSBIRT to Reduce Serious Teen Health Risks Phase 1/Phase 2
Completed NCT00970372 - Dual-Diagnosis and Compulsory Treatment N/A
Completed NCT01365247 - Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD) N/A
Completed NCT00419029 - Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment N/A